246 related articles for article (PubMed ID: 27034986)
1. FOXA1 defines cancer cell specificity.
Zhang G; Zhao Y; Liu Y; Kao LP; Wang X; Skerry B; Li Z
Sci Adv; 2016 Mar; 2(3):e1501473. PubMed ID: 27034986
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of the HSP72 by Foxa1 in MCF-7 human breast cancer cell line.
Song L; Xu Z; Zhang C; Qiao X; Huang C
Biochem Biophys Res Commun; 2009 Aug; 386(1):30-4. PubMed ID: 19486887
[TBL] [Abstract][Full Text] [Related]
3. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.
Lupien M; Eeckhoute J; Meyer CA; Wang Q; Zhang Y; Li W; Carroll JS; Liu XS; Brown M
Cell; 2008 Mar; 132(6):958-70. PubMed ID: 18358809
[TBL] [Abstract][Full Text] [Related]
4. NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.
Grabowska MM; Elliott AD; DeGraff DJ; Anderson PD; Anumanthan G; Yamashita H; Sun Q; Friedman DB; Hachey DL; Yu X; Sheehan JH; Ahn JM; Raj GV; Piston DW; Gronostajski RM; Matusik RJ
Mol Endocrinol; 2014 Jun; 28(6):949-64. PubMed ID: 24801505
[TBL] [Abstract][Full Text] [Related]
5. FOXA1 knock-out via CRISPR/Cas9 altered Casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.
Albayrak G; Konac E; Ugras Dikmen A; Bilen CY
Exp Biol Med (Maywood); 2018 Aug; 243(12):990-994. PubMed ID: 30043639
[TBL] [Abstract][Full Text] [Related]
6. Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines.
Yang L; Kumegawa K; Saeki S; Nakadai T; Maruyama R
Cancer Gene Ther; 2024 May; 31(5):736-745. PubMed ID: 38429368
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis reveals positional-nucleosome-oriented binding pattern of pioneer factor FOXA1.
Ye Z; Chen Z; Sunkel B; Frietze S; Huang TH; Wang Q; Jin VX
Nucleic Acids Res; 2016 Sep; 44(16):7540-54. PubMed ID: 27458208
[TBL] [Abstract][Full Text] [Related]
8. Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer.
Jing X; Liang H; Hao C; Hongxia L; Cui X
Aging (Albany NY); 2019 Sep; 11(18):7442-7456. PubMed ID: 31562808
[TBL] [Abstract][Full Text] [Related]
9. Pioneer of prostate cancer: past, present and the future of FOXA1.
Teng M; Zhou S; Cai C; Lupien M; He HH
Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
[TBL] [Abstract][Full Text] [Related]
10. Unique ERalpha cistromes control cell type-specific gene regulation.
Krum SA; Miranda-Carboni GA; Lupien M; Eeckhoute J; Carroll JS; Brown M
Mol Endocrinol; 2008 Nov; 22(11):2393-406. PubMed ID: 18818283
[TBL] [Abstract][Full Text] [Related]
11. FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function.
Yang YA; Zhao JC; Fong KW; Kim J; Li S; Song C; Song B; Zheng B; He C; Yu J
Nucleic Acids Res; 2016 Sep; 44(17):8153-64. PubMed ID: 27257062
[TBL] [Abstract][Full Text] [Related]
12. A systematic approach identifies FOXA1 as a key factor in the loss of epithelial traits during the epithelial-to-mesenchymal transition in lung cancer.
Wang H; Meyer CA; Fei T; Wang G; Zhang F; Liu XS
BMC Genomics; 2013 Oct; 14():680. PubMed ID: 24093963
[TBL] [Abstract][Full Text] [Related]
13. Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expression.
Sun Q; Yu X; Degraff DJ; Matusik RJ
Mol Endocrinol; 2009 Dec; 23(12):2038-47. PubMed ID: 19846536
[TBL] [Abstract][Full Text] [Related]
14. FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis.
Zhang Y; Tong T
Biochem Biophys Res Commun; 2014 Oct; 453(1):172-8. PubMed ID: 25264199
[TBL] [Abstract][Full Text] [Related]
15. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers.
Eeckhoute J; Lupien M; Meyer CA; Verzi MP; Shivdasani RA; Liu XS; Brown M
Genome Res; 2009 Mar; 19(3):372-80. PubMed ID: 19129543
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Analysis of the FOXA1 Transcriptional Network Identifies Novel Protein-Coding and Long Noncoding RNA Targets in Colorectal Cancer Cells.
Lazar SB; Pongor L; Li XL; Grammatikakis I; Muys BR; Dangelmaier EA; Redon CE; Jang SM; Walker RL; Tang W; Ambs S; Harris CC; Meltzer PS; Aladjem MI; Lal A
Mol Cell Biol; 2020 Oct; 40(21):. PubMed ID: 32839292
[TBL] [Abstract][Full Text] [Related]
17. Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.
Hu DG; Mackenzie PI
Drug Metab Dispos; 2010 Dec; 38(12):2105-9. PubMed ID: 20736324
[TBL] [Abstract][Full Text] [Related]
18. Nucleation of DNA repair factors by FOXA1 links DNA demethylation to transcriptional pioneering.
Zhang Y; Zhang D; Li Q; Liang J; Sun L; Yi X; Chen Z; Yan R; Xie G; Li W; Liu S; Xu B; Li L; Yang J; He L; Shang Y
Nat Genet; 2016 Sep; 48(9):1003-13. PubMed ID: 27500525
[TBL] [Abstract][Full Text] [Related]
19. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
20. Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation.
Sutinen P; Rahkama V; Rytinki M; Palvimo JJ
Mol Endocrinol; 2014 Oct; 28(10):1719-28. PubMed ID: 25127374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
